Bruker Invest
Overview
Bruker Invest is the corporate venture capital arm of Bruker Corporation, focusing on investments in life sciences and biotechnology companies. The firm seeks to support innovative companies that align with Bruker's mission to improve the quality of human life through scientific advancements. Bruker Invest's portfolio includes companies specializing in drug discovery, diagnostics, and other areas within the life sciences sector. The firm typically invests in early to growth-stage companies, providing capital to accelerate their development and commercialization efforts. Bruker Invest's strategic investments aim to foster collaboration between Bruker and its portfolio companies, leveraging Bruker's expertise in scientific instruments and analytical solutions to drive innovation in the life sciences industry. By partnering with emerging companies, Bruker Invest contributes to the advancement of healthcare and scientific research, aligning with Bruker's commitment to enabling breakthrough discoveries and applications that enhance human health and well-being.
Investment Focus
- Innovative technologies in life sciences and biotechnology
- Alignment with Bruker's mission and strategic objectives
- Potential for significant impact in the healthcare sector
- Strong management teams with a track record of success
- Scalable business models with clear paths to commercialization
- Opportunities for strategic collaboration with Bruker Corporation
Portfolio Companies
Reach Bruker Invest directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bruker Invest
What sectors does Bruker Invest invest in?
Bruker Invest invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Massachusetts, United States. Bruker Invest is listed as a corporate vc in the ConnectSafely investor database.
What stage does Bruker Invest invest at?
Bruker Invest backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Bruker Invest invest in?
Bruker Invest invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Bruker Invest invested in?
Bruker Invest's portfolio includes Haystack Oncology, Mercy BioAnalytics, Terrain BioSciences, Tome Biosciences, Akribion Therapeutics, NovAliX, Acuamark Diagnostics and IONpath.
Last updated · Source: ConnectSafely investor database
